Patient selection for left ventricular assist device implantation. The main problems
- Authors: Narusov O.Y.1, Shahramanova J.A.1, Amanatova V.A.1, Sychev A.V.1, Osmolovskaya Y.F.1, Ganaev K.G.1, Shiryaev A.A.1, Merkulova I.A.1, Pevzner D.V.1, Makeev M.I.1, Saidova M.A.1, Paleev F.N.1, Akchurin R.S.1, Tereshchenko S.N.1, Boytsov S.A.1
-
Affiliations:
- Chazov National Medical Research Center of Cardiology
- Issue: Vol 96, No 9 (2024): Кардиология
- Pages: 885-891
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/267774
- DOI: https://doi.org/10.26442/00403660.2024.09.202851
- ID: 267774
Cite item
Full Text
Abstract
Aim. To analyze the experience of Chazov National Medical Research Center of Cardiology in patient selection for left ventricular assist device (LVAD) implantation.
Materials and methods. 901 patients, whose documents were sent to Chazov National Medical Research Center of Cardiology from regional medical and prophylactic institutions, were screened as selection for LVAD implantation. Firstly, all patients underwent transthoracic echocardiography performed according to the extended protocol with a comprehensive assessment of the left and right ventricle size and function. Patients who underwent the screening procedure underwent further examination including both laboratory and instrumental diagnostic methods. In addition, the polyclinic database of patients diagnosed with chronic heart failure (CHF) and dilated cardiomyopathy was also analyzed.
Results. Among 901 screened patients 7.9% were suitable candidates for LVAD implantation and only 23 (2.6%) patients underwent surgery. Among those not eligible for surgery: 208 (29%) patients were not on optimal medical therapy, 15% of patients had indications for other surgical treatment of CHF, 12% of patients had severe right ventricular failure, 9.8% had severe comorbidities, 6.8% of patients refused surgery.
Conclusions. The main problems of selection for LVAD implantation were: low awareness of doctors about the introduction of new treatment methods, poor quality of transthoracic echocardiography, a large percentage of patients not receiving basic therapy for CHF, untimely referral of patients for other types of surgical treatment.
Full Text
##article.viewOnOriginalSite##About the authors
Oleg Yu. Narusov
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0003-2960-0950
SPIN-code: 2972-2883
Scopus Author ID: 55409543900
кандидат медицинских наук, старший научный сотрудник отделения заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowJanna A. Shahramanova
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: Jane-20498@mail.ru
ORCID iD: 0009-0007-9478-9530
SPIN-code: 5188-9200
аспирант отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowValeriia A. Amanatova
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-0678-9538
SPIN-code: 1058-0239
кандидат медицинских наук, науч. сотрудник отделения заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowAleksei V. Sychev
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
SPIN-code: 5855-8772
кандидат медицинских наук, врач-кардиолог отделения заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowYulia F. Osmolovskaya
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-7827-2618
SPIN-code: 3638-7077
кандидат медицинских наук, зав. 8-м кардиологическим отделением, научный сотрудник отделения заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowKamil G. Ganaev
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-8438-2450
SPIN-code: 2902-5643
кандидат медицинских наук, младший научный сотрудник лаборатории микрохирургии сердца и сосудов отд-ния сердечно-сосудистой хирургии
Russian Federation, MoscowAndrey A. Shiryaev
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-3325-9743
SPIN-code: 8710-6679
чл.-кор. РАН доктор медицинских наук, профессор, рук. лаборатории микрохирургии сердца и сосудов сердечно-сосудистой хирургии
Russian Federation, MoscowIrina A. Merkulova
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0001-7461-3422
SPIN-code: 6169-1588
врач-кардиолог палаты реанимации и интенсивной терапии, младший научный сотрудник отделения неотложной кардиологии
Russian Federation, MoscowDmitry V. Pevzner
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-5290-0065
SPIN-code: 9982-5926
кандидат медицинских наук, ведущий научный сотрудник отделения неотложной кардиологии
Russian Federation, MoscowMaksim I. Makeev
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-4779-5088
SPIN-code: 3920-3674
врач ультразвуковой диагностики
Russian Federation, MoscowMarina A. Saidova
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-3233-1862
SPIN-code: 8957-8600
доктор медицинских наук, профессор, руководитель отделения ультразвуковых методов исследования
Russian Federation, MoscowFilipp N. Paleev
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0001-9481-9639
SPIN-code: 1706-0597
чл.-кор. РАН доктор медицинских наук, профессор, первый зам. ген. директора
Russian Federation, Moscow
Renat S. Akchurin
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0002-2105-8258
SPIN-code: 6756-8930
академик РАН доктор медицинских наук, профессор, зам. ген. директора по хирургии, руководитель отделения сердечно-сосудистой хирургии
Russian Federation, MoscowSergey N. Tereshchenko
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0001-9234-6129
SPIN-code: 9556-2575
доктор медицинских наук, профессор, руководитель отделения заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowSergey A. Boytsov
Chazov National Medical Research Center of Cardiology
Email: Jane-20498@mail.ru
ORCID iD: 0000-0001-6998-8406
SPIN-code: 7961-5520
академик РАН доктор медицинских наук, профессор, ген. директор
Russian Federation, MoscowReferences
- Schlendorf KH, Russell SD. New diagnostic devices in heart failure. Curr Opin Cardiol. 2010;25(3):262-7. doi: 10.1097/HCO.0b013e3283387962
- Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: Patient selection and outcomes. European Journal of Heart Failure. 2017;19(5):595-602. doi: 10.1002/ejhf.779
- Сафиуллина А.А., Ускач Т.М., Добровольская С.В., и др. Ремоделирование миокарда у пациентов с хронической сердечной недостаточностью и имплантированными модуляторами сердечной сократимости. Терапевтический архив. 2021;93(12):1443-50 [Safiullina AA, Uskach TM, Dobrovolskaya SV, et al. Myocardial remodeling in patients with chronic heart failure and implanted cardiac contractility modulators. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(12):1443-50 (in Russian)]. doi: 10.26442/00403660.2021.12.201218
- Vieira JL, Ventura HO, Mehra MR. Mechanical circulatory support devices in advanced heart failure: 2020 and beyond. Prog Cardiovasc Dis. 2020;63(5):630-9. doi: 10.1016/j.pcad.2020.09.003
- Michaels A, Cowger J. Patient Selection for Destination LVAD Therapy: Predicting Success in the Short and Long Term. Curr Heart Fail Rep. 2019;16(5):140-9. doi: 10.1007/s11897-019-00434-1
- Шахраманова Ж.А., Аманатова В.А., Нарусов О.Ю., и др. Особенности оценки гемодинамики у пациентов с центрифугальной системой вспомогательного кровообращения. Кардиологический вестник. 2023;18(3):6-15 [Shahramanova ZhA, Amanatova VA, Narusov OYu, et al. Peculiarities of hemodynamic assessment in patients with centrifugal circulatory assist system. Russian Cardiology Bulletin. 2023;18(3):6-15 (in Russian)]. doi: 10.17116/Cardiobulletin2023180316
- Rector TS, Taylor BC, Greer N, et al. Use of left ventricular assist devices as destination therapy in end-stage congestive heart failure: A systematic review. Washington (DC): Department of Veterans Affairs (US), 2012. PMID: 22855974
- McDonagh TA, Metra M, Adamo M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi: 10.1093/eurheartj/ehab368. Erratum in: Eur Heart J. 2021;42(48):4901. doi: 10.1093/eurheartj/ehab670
- Yuzefpolskaya M, Schroeder SE, Houston BA, et al. The Society of Thoracic Surgeons Intermacs 2022 annual report: Focus on the 2018 heart transplant allocation system. Ann Thorac Surg. 2023;115(2):311-27. doi: 10.1016/j.athoracsur.2022.11.023
- Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 2022;328(12):1233-42. doi: 10.1001/jama.2022.16197
- Mehra MR, Cleveland JC Jr, Uriel N, et al.; MOMENTUM 3 Investigators. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: A study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021;23(8):1392-400. doi: 10.1002/ejhf.2211
- Masarone D, Houston B, Falco L, et al. How to select patients for left ventricular assist devices? A Guide for Clinical Practice. J Clin Med. 2023;12(16):5216. doi: 10.3390/jcm12165216
- Varshney AS, DeFilippis EM, Cowger JA, et al. Trends and outcomes of left ventricular assist device therapy: JACC Focus Seminar. J Am Coll Cardiol. 2022;79(11):1092-107. doi: 10.1016/j.jacc.2022.01.017
- Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010;12(5):434-43. doi: 10.1093/eurjhf/hfq006
- Gautier SV, Shevchenko AO, Itkin GP, et al. Artificial heart in Russia: Past, present, and future. Artificial Organs. 2021;45(2):111-4. doi: 10.1111/aor.13860
- Frigerio M. Left ventricular assist device: Indication, timing, and management. Heart Fail Clin. 2021;17(4):619-34. doi: 10.1016/j.hfc.2021.05.007
- Lund LH, Trochu JN, Meyns B, et al. Screening for heart transplantation and left ventricular assist system: Results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study. Eur J Heart Fail. 2018;20(1):152-60. doi: 10.1002/ejhf.975
- Lietz K, Miller LW. Patient selection for left-ventricular assist devices. Curr Opin Cardiol. 2009;24(3):246-51. doi: 10.1097/HCO.0b013e32832a0743
- de By TMMH, Mohacsi P, Gahl B, et al.; EUROMACS members. The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): Second report. Eur J Cardiothorac Surg. 2018;53(2):309-16. doi: 10.1093/ejcts/ezx320
- Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg. 2003;75(Suppl. 6):S29-35. doi: 10.1016/s0003-4975(03)00461-2
Supplementary files
